Jeffrey Wiezorek, SVP Clinical Development at Kite Pharma, Inc. (KITE), sold 10,000 shares at $104.26 ($1.0M) on 2017-07-03, disclosed to the SEC on 2017-07-06.
Open-market sale of $1.0M KITE by SVP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.26 | 8,799 | $917K | 87.9% |
| 2 | $104.76 | 1,201 | $126K | 12.1% |
| Total | $104.32 avg | 10,000 | $1.0M | 100% |
| Filing → |
| KITE | SELL | 2017-07-06 | $126K | — | Filing → |
| KITE | SELL | 2017-03-02 | $1.4M | — | Filing → |
| KITE | SELL | 2017-02-06 | $77K | — | Filing → |